Skip to content

Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function

Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01395719
Acronym
Context
Enrollment
220
Registered
2011-07-15
Start date
2011-06-30
Completion date
2016-06-30
Last updated
2015-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Delayed Graft Function, Glomerular Filtration Rate, Kidney Transplantation

Keywords

renal transplantation, glomerular filtration rate, remote ischemic preconditioning, remote ischemic conditioning

Brief summary

The purpose of this study is to determine whether remote ischemic conditioning can improve the outcome after renal transplantation with deceased donor. Remote ischemic conditioning is performed on the patient receiving a kidney from a deceased donor. Remote ischemic conditioning is done during the operation by inflating a tourniquet on the patients leg before opening the blood circulation to the kidney. The study focus on both the immediate kidney function after the transplantation, but also on the extended kidney function one year after the transplantation.

Interventions

OTHERRemote ischemic conditioning

Patients receiving kidney transplantation from a deceased donor. Remote ischemic conditioning (rIC) is done by inflating a tourniquet (250mmHg) on the patients leg before reperfusion of the kidney. The tourniquet stays on the leg on the opposite site of were the kidney is placed. rIC is done 4 x 5 min with 5 min intervals between with free blood flow.

Sponsors

Sahlgrenska University Hospital
CollaboratorOTHER
Lundbeck Foundation
CollaboratorOTHER
Novo Nordisk A/S
CollaboratorINDUSTRY
AP Moeller Foundation
CollaboratorOTHER
Danish Society of Nephrology
CollaboratorOTHER
Aarhus University Hospital
CollaboratorOTHER
Erasmus Medical Center
CollaboratorOTHER
University Medical Center Groningen
CollaboratorOTHER
Danish Council for Independent Research
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 and above * Received information, signed consent * Candidate for kidney transplantation from deceased donor

Exclusion criteria

* Can't give informed consent * AV-fistula in the leg opposite the site where the graft will be placed * Threatening ischemia in the leg * If donor is a small child * If the patient receives a double transplant

Design outcomes

Primary

MeasureTime frameDescription
Time to a 50% drop in baseline plasma-creatinineminimum 1 weekPlasma-creatinine changes posttransplant will be described using an exponential/logistic/linear model depending on the individual patient data. All plasma-creatinine values 30 days posttransplant, or in case of temporary posttransplant dialysis 30 days after the last performed dialysis, will be used, measured minimum twice daily initially. Baseline plasma-creatinine is measured approximately 1 hour prior to reperfusion of the kidney. Time to a 50% drop in baseline plasma-creatinine will be estimated.

Secondary

MeasureTime frameDescription
Need for dialysis1 week
GFR after 1 year12 monthsGFR measurement by Cr-EDTA.

Countries

Denmark, Netherlands, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026